313 related articles for article (PubMed ID: 19155295)
1. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.
Chinnadurai G
Cancer Res; 2009 Feb; 69(3):731-4. PubMed ID: 19155295
[TBL] [Abstract][Full Text] [Related]
2. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
Blevins MA; Huang M; Zhao R
Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
[TBL] [Abstract][Full Text] [Related]
3. C-terminal binding proteins: central players in development and disease.
Stankiewicz TR; Gray JJ; Winter AN; Linseman DA
Biomol Concepts; 2014 Dec; 5(6):489-511. PubMed ID: 25429601
[TBL] [Abstract][Full Text] [Related]
4. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
5. CtBPs promote cell survival through the maintenance of mitotic fidelity.
Bergman LM; Birts CN; Darley M; Gabrielli B; Blaydes JP
Mol Cell Biol; 2009 Aug; 29(16):4539-51. PubMed ID: 19506021
[TBL] [Abstract][Full Text] [Related]
6. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases.
Chen Z
J Mol Med (Berl); 2021 Oct; 99(10):1335-1347. PubMed ID: 34196767
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation by C-terminal binding proteins.
Chinnadurai G
Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
[TBL] [Abstract][Full Text] [Related]
8. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.
Kuppuswamy M; Vijayalingam S; Zhao LJ; Zhou Y; Subramanian T; Ryerse J; Chinnadurai G
Mol Cell Biol; 2008 Jan; 28(1):269-81. PubMed ID: 17967884
[TBL] [Abstract][Full Text] [Related]
9. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
[TBL] [Abstract][Full Text] [Related]
10. Structurally related Arabidopsis ANGUSTIFOLIA is functionally distinct from the transcriptional corepressor CtBP.
Stern MD; Aihara H; Cho KH; Kim GT; Horiguchi G; Roccaro GA; Guevara E; Sun HH; Negeri D; Tsukaya H; Nibu Y
Dev Genes Evol; 2007 Dec; 217(11-12):759-69. PubMed ID: 17972097
[TBL] [Abstract][Full Text] [Related]
11. Identification of CtBP1 and CtBP2 as corepressors of zinc finger-homeodomain factor deltaEF1.
Furusawa T; Moribe H; Kondoh H; Higashi Y
Mol Cell Biol; 1999 Dec; 19(12):8581-90. PubMed ID: 10567582
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
13. CPP-E1A fusion peptides inhibit CtBP-mediated transcriptional repression.
Blevins MA; Zhang C; Zhang L; Li H; Li X; Norris DA; Huang M; Zhao R
Mol Oncol; 2018 Aug; 12(8):1358-1373. PubMed ID: 29879296
[TBL] [Abstract][Full Text] [Related]
14. C-terminal binding proteins (CtBPs) attenuate KLF4-mediated transcriptional activation.
Liu G; Zheng H; Ai W
FEBS Lett; 2009 Oct; 583(19):3127-32. PubMed ID: 19751731
[TBL] [Abstract][Full Text] [Related]
15. The Caenorhabditis elegans protein CTBP-1 defines a new group of THAP domain-containing CtBP corepressors.
Nicholas HR; Lowry JA; Wu T; Crossley M
J Mol Biol; 2008 Jan; 375(1):1-11. PubMed ID: 18005989
[TBL] [Abstract][Full Text] [Related]
16. CtBPs promote mitotic fidelity through their activities in the cell nucleus.
Birts CN; Bergman LM; Blaydes JP
Oncogene; 2011 Mar; 30(11):1272-80. PubMed ID: 21057548
[TBL] [Abstract][Full Text] [Related]
17. A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.
Pagan JK; Arnold J; Hanchard KJ; Kumar R; Bruno T; Jones MJ; Richard DJ; Forrest A; Spurdle A; Verdin E; Crossley M; Fanciulli M; Chenevix-Trench G; Young DB; Khanna KK
J Biol Chem; 2007 May; 282(20):15248-57. PubMed ID: 17379597
[TBL] [Abstract][Full Text] [Related]
18. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
Paliwal S; Kovi RC; Nath B; Chen YW; Lewis BC; Grossman SR
Cancer Res; 2007 Oct; 67(19):9322-9. PubMed ID: 17909040
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation is involved in the pathogenesis of osteoarthritis by regulating
Sun X; Xiao L; Chen J; Chen X; Chen X; Yao S; Li H; Zhao G; Ma J
Int J Biol Sci; 2020; 16(6):994-1009. PubMed ID: 32140068
[TBL] [Abstract][Full Text] [Related]
20. CtBP, an unconventional transcriptional corepressor in development and oncogenesis.
Chinnadurai G
Mol Cell; 2002 Feb; 9(2):213-24. PubMed ID: 11864595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
